Melinda Soeung

9PUBLICATIONS
117CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer cell biologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Mar 05, 2025
Evolutionary fingerprints of epithelial-to-mesenchymal transition.

Luigi Perelli, Li Zhang, Sarah Mangiameli

|May 31, 2024
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma.

Clare F Malone, Nathaniel W Mabe, Alexandra B Forman

|Mar 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancer.

I-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang

Pageof 2

Frequent Collaborators

7 joint publications

Giulio F Draetta

6 joint publications

Linghua Wang

5 joint publications

Andrew Futreal

5 joint publications

Giannicola Genovese